November 05, 2026 at 09:03 PM UTC
8-K - BridgeBio Oncology Therapeutics, Inc. (0001869105) (Filer)
Filed: 2026-11-05 AccNo: 0001193125-26-449722 Size: 140 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Official source: U.S. Securities and Exchange Commission
Official source published: November 05, 2026 at 09:01 PM UTC
Open official source